| 1.18 0.07 (6.31%) | 07-27 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.49  |
1-year : | 1.65 |
| Resists | First : | 1.28 |
Second : | 1.41 |
| Pivot price | 1.15 |
|||
| Supports | First : | 1.06 |
Second : | 0.88 |
| MAs | MA(5) : | 1.13 |
MA(20) : | 1.18 |
| MA(100) : | 1.69 |
MA(250) : | 1.79 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 25.1 |
D(3) : | 16.4 |
| RSI | RSI(14): 42.8 |
|||
| 52-week | High : | 3.63 | Low : | 0.62 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AIFF ] has closed below upper band by 38.7%. Bollinger Bands are 79.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.19 - 1.2 | 1.2 - 1.2 |
| Low: | 1.05 - 1.05 | 1.05 - 1.06 |
| Close: | 1.17 - 1.18 | 1.18 - 1.19 |
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Mon, 27 Jul 2026
Firefly Neuroscience Inc (AIFF) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mon, 27 Jul 2026
Firefly Neuroscience Inc (AIFF) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sat, 25 Jul 2026
Firefly Neuroscience, Inc. Revenue Breakdown – NASDAQ:AIFF - TradingView
Fri, 10 Jul 2026
AIFF Should I Buy - Intellectia AI
Thu, 09 Jul 2026
Firefly Neuroscience (AIFF) 2026 proxy seeks votes on directors, pay and cutting authorized shares - Stock Titan
Fri, 26 Jun 2026
Enterprise value to revenue forward of Firefly Neuroscience, Inc. – NASDAQ:AIFF - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 0 (M) |
| Shares Float | 16 (M) |
| Held by Insiders | 1.424e+007 (%) |
| Held by Institutions | 28.2 (%) |
| Shares Short | 748 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -8.38e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -414.5 % |
| Return on Assets (ttm) | -45.7 % |
| Return on Equity (ttm) | -131.5 % |
| Qtrly Rev. Growth | 1 % |
| Gross Profit (p.s.) | 0.04 |
| Sales Per Share | 0.07 |
| EBITDA (p.s.) | -0.58 |
| Qtrly Earnings Growth | -0.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 15.3 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 655690 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|